Evidence map›Paper›PMID 40504744›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2025

Clinician perspectives on disclosing public health uses of HIV antiretroviral resistance testing results.

Juli Bollinger, Gail Geller, Sanjay R Mehta, Susan J Little, Jeremy Sugarman

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Juli BollingerBerman Institute of Bioethics, Johns Hopkins University, Baltimore, MD, USA.ORCID 0000-0001-6850-8562
Gail GellerBerman Institute of Bioethics, Johns Hopkins University, Baltimore, MD, USA.ORCID 0000-0003-4856-1942
Sanjay R MehtaDivision of Infectious Diseases, University of California San Diego, San Diego, CA, USA.ORCID 0000-0002-2028-8158
Susan J LittleDivision of Infectious Diseases, University of California San Diego, San Diego, CA, USA.ORCID 0000-0002-7645-9737
Jeremy SugarmanBerman Institute of Bioethics, Johns Hopkins University, Baltimore, MD, USA.ORCID 0000-0001-7022-8332

Funding

VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Maile Ann Young Karris · 1994 to 2026
$78.4M
Risks, Benefits, and Stakeholder Perspectives of Molecular Epidemiology for HIV Prevention (HIV-ME)R01MH124590 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LITTLE, SUSAN JANET, SUGARMAN, JEREMY · 2020 to 2024
$3.9M
NIAID NIH HHS P30 AI036214NIMH NIH HHS R01 MH124590
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40504744
PMCPMC12414491

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.